Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination
- PMID: 34178302
- PMCID: PMC8207278
- DOI: 10.1177/20420986211021233
Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination
Abstract
Background: Identifying pregnancy episodes and accurately estimating their beginning and end dates are imperative for observational maternal vaccine safety studies using electronic health record (EHR) data.
Methods: We modified the Vaccine Safety Datalink (VSD) Pregnancy Episode Algorithm (PEA) to include both the International Classification of Disease, ninth revision (ICD-9 system) and ICD-10 diagnosis codes, incorporated additional gestational age data, and validated this enhanced algorithm with manual medical record review. We also developed the new Dynamic Pregnancy Algorithm (DPA) to identify pregnancy episodes in real time.
Results: Around 75% of the pregnancy episodes identified by the enhanced VSD PEA were live births, 12% were spontaneous abortions (SABs), 10% were induced abortions (IABs), and 0.4% were stillbirths (SBs). Gestational age was identified for 99% of live births, 89% of SBs, 69% of SABs, and 42% of IABs. Agreement between the PEA-assigned and abstractor-identified pregnancy outcome and outcome date was 100% for live births, but was lower for pregnancy losses. When gestational age was available in the medical record, the agreement was higher for live births (97%), but lower for pregnancy losses (75%). The DPA demonstrated strong concordance with the PEA and identified pregnancy episodes ⩾6 months prior to the outcome date for 89% of live births.
Conclusion: The enhanced VSD PEA is a useful tool for identifying pregnancy episodes in EHR databases. The DPA improves the timeliness of pregnancy identification and can be used for near real-time maternal vaccine safety studies.
Plain language summary: Improving identification of pregnancies in the Vaccine Safety Datalink electronic medical record databases to allow for better and faster monitoring of vaccination safety during pregnancy Introduction: It is important to monitor of the safety of vaccines after they have been approved and licensed by the Food and Drug Administration, especially among women vaccinated during pregnancy. The Vaccine Safety Datalink (VSD) monitors vaccine safety through observational studies within large databases of electronic medical records. Since 2012, VSD researchers have used an algorithm called the Pregnancy Episode Algorithm (PEA) to identify the medical records of women who have been pregnant. Researchers then use these medical records to study whether receiving a particular vaccine is linked to any negative outcomes for the woman or her child.Methods: The goal of this study was to update and enhance the PEA to include the full set of medical record diagnostic codes [both from the older International Classification of Disease, ninth revision (ICD-9 system) and the newer ICD-10 system] and to incorporate additional sources of data about gestational age. To ensure the validity of the PEA following these enhancements, we manually reviewed medical records and compared the results with the algorithm. We also developed a new algorithm, the Dynamic Pregnancy Algorithm (DPA), to identify women earlier in pregnancy, allowing us to conduct more timely vaccine safety assessments.Results: The new version of the PEA identified 2,485,410 pregnancies in the VSD database. The enhanced algorithm more precisely estimated the beginning of pregnancies, especially those that did not result in live births, due to the new sources of gestational age data.Conclusion: Our new algorithm, the DPA, was successful at identifying pregnancies earlier in gestation than the PEA. The enhanced PEA and the new DPA will allow us to better evaluate the safety of current and future vaccinations administered during or around the time of pregnancy.
Keywords: algorithm; immunization; pregnancy; safety.
© The Author(s), 2021.
Conflict of interest statement
Conflict of interest statement: ALN has received research funding from Pfizer for unrelated work. NPK has received research funding from GlaxoSmithKline, Pfizer, Sanofi Pasteur, and Merck Protein Science (now Sanofi Pasteur) for unrelated work. The VSD Project is funded by the CDC. The funders of this study had no role in the design of the study, data collection, data analysis, data interpretation, or writing of the report. The manuscript was approved by the CDC clearance process.
Figures
![Figure 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8207278/bin/10.1177_20420986211021233-fig1.gif)
![Figure 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8207278/bin/10.1177_20420986211021233-fig2.gif)
![Figure 3.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8207278/bin/10.1177_20420986211021233-fig3.gif)
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
COVID-19 vaccination in pregnancy: early experience from a single institution.Am J Obstet Gynecol MFM. 2021 Nov;3(6):100464. doi: 10.1016/j.ajogmf.2021.100464. Epub 2021 Aug 16. Am J Obstet Gynecol MFM. 2021. PMID: 34411758 Free PMC article.
-
The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety.Vaccine. 2014 Sep 22;32(42):5390-8. doi: 10.1016/j.vaccine.2014.07.073. Epub 2014 Aug 6. Vaccine. 2014. PMID: 25108215 Free PMC article. Review.
-
Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink.Vaccine. 2013 Jun 12;31(27):2898-903. doi: 10.1016/j.vaccine.2013.03.069. Epub 2013 Apr 30. Vaccine. 2013. PMID: 23639917
-
The Vaccine Safety Datalink: a model for monitoring immunization safety.Pediatrics. 2011 May;127 Suppl 1:S45-53. doi: 10.1542/peds.2010-1722H. Epub 2011 Apr 18. Pediatrics. 2011. PMID: 21502240 Review.
Cited by
-
Attitudes Toward COVID-19 Vaccines Among Pregnant and Recently Pregnant Individuals.JAMA Netw Open. 2024 Apr 1;7(4):e245479. doi: 10.1001/jamanetworkopen.2024.5479. JAMA Netw Open. 2024. PMID: 38587844 Free PMC article.
-
Racial and ethnic disparities in influenza vaccination coverage among pregnant women in the United States: The contribution of vaccine-related attitudes.Prev Med. 2023 Dec;177:107751. doi: 10.1016/j.ypmed.2023.107751. Epub 2023 Nov 4. Prev Med. 2023. PMID: 37926397 Free PMC article.
-
Who is pregnant? Defining real-world data-based pregnancy episodes in the National COVID Cohort Collaborative (N3C).JAMIA Open. 2023 Aug 16;6(3):ooad067. doi: 10.1093/jamiaopen/ooad067. eCollection 2023 Oct. JAMIA Open. 2023. PMID: 37600074 Free PMC article.
-
Influenza Vaccination Among Pregnant People Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic.Obstet Gynecol. 2023 Sep 1;142(3):636-639. doi: 10.1097/AOG.0000000000005285. Epub 2023 Aug 3. Obstet Gynecol. 2023. PMID: 37590982 Free PMC article.
-
COVID-19 vaccine registry for pregnant women: policy to control complications of vaccination in pregnant women in 2021-2022.BMC Pregnancy Childbirth. 2023 Jul 27;23(1):542. doi: 10.1186/s12884-023-05856-3. BMC Pregnancy Childbirth. 2023. PMID: 37501112 Free PMC article.
References
-
- Naleway AL, Kurosky S, Henninger ML, et al.. Vaccinations given during pregnancy, 2002-2009: a descriptive study. Am J Prev Med 2014; 46: 150–157. - PubMed
-
- Goss MA, Lievano F, Buchanan KM, et al.. Final report on exposure during pregnancy from a pregnancy registry for quadrivalent human papillomavirus vaccine. Vaccine 2015; 33: 3422–3428. - PubMed
LinkOut - more resources
Full Text Sources